🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
Background: Colorectal cancer is a common cancer in the Unites States (U.S...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center
Start Date
2017-04-05
Trial ID
NCT03050814
This study is researching an investigational drug, called BNT116, in combin...
Status
Active Not Recruiting
Location
The Oncology Institute of Hope and Innovation
Start Date
2023-04-21
Trial ID
NCT05557591
Treatments Being Tested
This study will investigate the safety and effectiveness of a new combinati...
Status
Recruiting
Location
Tongji Hospital
Start Date
2026-01-30
Trial ID
NCT07392541
Treatments Being Tested
The objective of this study is to evaluate in a 3 +3 design, the safety of ...
Status
Completed
Location
University of California, Moores Cancer Center
Start Date
2015-12
Trial ID
NCT02643550
Treatments Being Tested
JTX-2011-201 is a Phase 2, open label clinical study of vopratelimab (JTX-2...
Status
Completed
Location
Beverly Hills Cancer Center
Start Date
2019-06-06
Trial ID
NCT03989362
Treatments Being Tested
This study is a single-arm, multi-center, prospective clinical study aimed ...
Status
Not Yet Recruiting
Location
The Second Affiliated Hospital of Soochow University
Start Date
2025-12-27
Trial ID
NCT07327411
Treatments Being Tested
This phase I/II trial studies the side effects of gene-modified immune cell...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2019-07-03
Trial ID
NCT03747484
using Atezolizumab, a PD-L1 inhibitor, in combination with bevacizumab, pla...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2020-04-10
Trial ID
NCT04147351
Treatments Being Tested